RU2681196C2 - Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска - Google Patents
Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска Download PDFInfo
- Publication number
- RU2681196C2 RU2681196C2 RU2016150847A RU2016150847A RU2681196C2 RU 2681196 C2 RU2681196 C2 RU 2681196C2 RU 2016150847 A RU2016150847 A RU 2016150847A RU 2016150847 A RU2016150847 A RU 2016150847A RU 2681196 C2 RU2681196 C2 RU 2681196C2
- Authority
- RU
- Russia
- Prior art keywords
- user
- health
- indicators
- health indicators
- values
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000012544 monitoring process Methods 0.000 title claims abstract description 19
- 230000000771 oncological effect Effects 0.000 title description 8
- 230000036541 health Effects 0.000 claims abstract description 82
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 25
- 239000011159 matrix material Substances 0.000 claims abstract description 22
- 201000011510 cancer Diseases 0.000 claims abstract description 20
- 238000012545 processing Methods 0.000 claims abstract description 16
- 238000004458 analytical method Methods 0.000 claims abstract description 9
- 238000013500 data storage Methods 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 4
- 238000005259 measurement Methods 0.000 claims abstract description 3
- 238000009534 blood test Methods 0.000 claims description 5
- 210000000056 organ Anatomy 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims description 4
- 238000003325 tomography Methods 0.000 claims description 3
- 238000002604 ultrasonography Methods 0.000 claims description 3
- 238000002562 urinalysis Methods 0.000 claims description 3
- 230000003252 repetitive effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 230000005540 biological transmission Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 2
- 230000003862 health status Effects 0.000 abstract description 2
- 238000004891 communication Methods 0.000 description 6
- 238000007726 management method Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013499 data model Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000005495 thyroid hormone Substances 0.000 description 2
- 229940036555 thyroid hormone Drugs 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 208000032236 Predisposition to disease Diseases 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960000874 thyrotropin Drugs 0.000 description 1
- 230000001748 thyrotropin Effects 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Primary Health Care (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2016/000923 WO2018117899A1 (ru) | 2016-12-23 | 2016-12-23 | Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска |
| RU2016150847A RU2681196C2 (ru) | 2016-12-23 | 2016-12-23 | Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016150847A RU2681196C2 (ru) | 2016-12-23 | 2016-12-23 | Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016150847A3 RU2016150847A3 (nl) | 2018-06-25 |
| RU2016150847A RU2016150847A (ru) | 2018-06-25 |
| RU2681196C2 true RU2681196C2 (ru) | 2019-03-04 |
Family
ID=62626831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016150847A RU2681196C2 (ru) | 2016-12-23 | 2016-12-23 | Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска |
Country Status (2)
| Country | Link |
|---|---|
| RU (1) | RU2681196C2 (nl) |
| WO (1) | WO2018117899A1 (nl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109585022A (zh) * | 2018-11-21 | 2019-04-05 | 北京天和智慧健康管理有限公司 | 一种用于癌症风险评估的设备和系统 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060135859A1 (en) * | 2004-10-22 | 2006-06-22 | Iliff Edwin C | Matrix interface for medical diagnostic and treatment advice system and method |
| US20070156453A1 (en) * | 2005-10-07 | 2007-07-05 | Brainlab Ag | Integrated treatment planning system |
| RU2468434C2 (ru) * | 2006-10-12 | 2012-11-27 | Конинклейке Филипс Электроникс Н.В. | Система поддержки принятия клинических решений |
-
2016
- 2016-12-23 WO PCT/RU2016/000923 patent/WO2018117899A1/ru active Application Filing
- 2016-12-23 RU RU2016150847A patent/RU2681196C2/ru active IP Right Revival
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060135859A1 (en) * | 2004-10-22 | 2006-06-22 | Iliff Edwin C | Matrix interface for medical diagnostic and treatment advice system and method |
| US20070156453A1 (en) * | 2005-10-07 | 2007-07-05 | Brainlab Ag | Integrated treatment planning system |
| RU2468434C2 (ru) * | 2006-10-12 | 2012-11-27 | Конинклейке Филипс Электроникс Н.В. | Система поддержки принятия клинических решений |
Non-Patent Citations (3)
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018117899A1 (ru) | 2018-06-28 |
| RU2016150847A3 (nl) | 2018-06-25 |
| RU2016150847A (ru) | 2018-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210090737A1 (en) | Method of hypoglycemia risk determination | |
| Low | Harnessing consumer smartphone and wearable sensors for clinical cancer research | |
| West et al. | Information quality challenges of patient-generated data in clinical practice | |
| Rothman et al. | Clinical implications and validity of nursing assessments: a longitudinal measure of patient condition from analysis of the Electronic Medical Record | |
| US20140068487A1 (en) | Computer Implemented Methods For Visualizing Correlations Between Blood Glucose Data And Events And Apparatuses Thereof | |
| Forsman et al. | Integrated information visualization to support decision making for use of antibiotics in intensive care: design and usability evaluation | |
| Gower et al. | A novel approach to evaluating mobile smartphone screen time for iPhones: Feasibility and preliminary findings | |
| CN109887611A (zh) | 一种医疗管理系统及移动终端 | |
| EP2541450A1 (en) | Patient mobile computing system and method for exacerbation prediction | |
| JP2015531916A (ja) | 分析物監視システムのユーザインタフェース | |
| TW201508688A (zh) | 施予健康照護系統之系統及方法 | |
| Alotaibi et al. | A mobile diabetes management and educational system for type-2 diabetics in Saudi Arabia (SAED) | |
| Cronin et al. | Patient and healthcare provider views on a patient-reported outcomes portal | |
| Pais et al. | Acceptance of using an ecosystem of mobile apps for use in diabetes clinic for self-management of gestational diabetes mellitus | |
| US20100125175A1 (en) | Icon-based healthcare interfaces based on health condition events | |
| EP3567594A1 (en) | Diabetes management system with dynamic selection of prediction logic | |
| Singh et al. | A review of EMA assessment period reporting for mood variables in substance use research: Expanding existing EMA guidelines | |
| Li et al. | The state of wearable health technologies: a transdisciplinary literature review | |
| TWI668664B (zh) | Method for dynamically analyzing blood sugar level, system thereof and computer program product | |
| RU2681196C2 (ru) | Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска | |
| Reychav et al. | Reporting health data in waiting rooms with mobile technology: Patient expectation and confirmation | |
| Pieczkiewicz et al. | Evaluating the decision accuracy and speed of clinical data visualizations | |
| Dempsey et al. | The High Price of Equity in Pulse Oximetry: A cost evaluation and need for interim solutions | |
| US20190216405A1 (en) | Method and system for determining a carbohydrate intake event from glucose monitoring data indicative of a glucose level, and a non-transitory computer readable medium | |
| Abdolkhani et al. | Recommendations for the quality management of patient-generated health data in remote patient monitoring: mixed methods study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HE9A | Changing address for correspondence with an applicant | ||
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20191224 |
|
| NF4A | Reinstatement of patent |
Effective date: 20210115 |